Advertisement
Canada markets close in 2 hours 51 minutes

  • S&P/TSX

    21,825.04
    +116.60 (+0.54%)
     

  • S&P 500

    4,987.78
    -23.34 (-0.47%)
     

  • DOW

    37,994.20
    +218.82 (+0.58%)
     

  • CAD/USD

    0.7276
    +0.0012 (+0.17%)
     

  • CRUDE OIL

    83.53
    +0.80 (+0.97%)
     

  • Bitcoin CAD

    88,276.02
    +1,064.89 (+1.22%)
     

  • CMC Crypto 200

    1,381.93
    +69.31 (+5.28%)
     

  • GOLD FUTURES

    2,414.10
    +16.10 (+0.67%)
     

  • RUSSELL 2000

    1,943.92
    +0.96 (+0.05%)
     

  • 10-Yr Bond

    4.6130
    -0.0340 (-0.73%)
     

  • NASDAQ

    15,388.79
    -212.71 (-1.36%)
     

  • VOLATILITY

    18.63
    +0.63 (+3.51%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     
MARKETS LIVE BLOG:

S&P 500 SLIPS BELOW 5,000; NASDAQ SINKS ON NETFLIX DRAG

Fed's Goolsbee says 'It makes sense to wait' before cutting rates

Up Cannabis-parent Newstrike's shareholders approve sale to CanniMed

Reuters

(Reuters) - Newstrike Resources Ltd's (TSXV:HIP.V - News) shareholders approved the sale of the Canadian cannabis producer to CanniMed Therapeutics Inc (Toronto:CMED.TO - News), which is fighting off a hostile takeover bid from fellow medical marijuana company Aurora Cannabis Inc (:ACB.TO).

CanniMed has a shareholder meeting on Jan. 23 to vote on the Newstrike acquisition, which Aurora has called a "terrible deal".

Earlier this month, CanniMed signed a deal with Up Cannabis, which is owned by Newstrike, for the supply of raw materials in the face of rising demand as Canada prepares to legalize recreational pot.

CanniMed has filed a $725 million lawsuit as it tries to fend off Aurora's hostile takeover.

(This version of the story was refiled to correct a typo in the headline)

(Reporting by Uday Sampath in Bengaluru; Editing by Savio D'Souza)